Concepedia

Author

Joanna Parkinson

AstraZeneca (Sweden)ORCID

Also Known As

J Parkinson, J. Parkinson, JOANNA R. PARKINSON, Joanna Parkinson

48

Publications

511

Citations

13

H-Index

21

Concepts

All Affiliations

AstraZeneca (Sweden)AstraZeneca (United Kingdom)AstraZeneca (United States)AstraZeneca (Poland)AstraZeneca (Australia)
JP

About

Joanna Parkinson is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

64

2

Engineering

1

1

25

3

Biostatistics

1

1

25

4

Data Science

1

1

25

5

Gastroenterology

1

1

25

Joanna Parkinson

×

14

Publications

365

Citations

13

H-Index

YearCitations

Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial

Austin G. Stack, Nalina Dronamraju, Joanna Parkinson,

American Journal of Kidney Diseases

2020

68

Parameter Identifiability of Fundamental Pharmacodynamic Models

David Janzén, Linnéa Bergenholm, Mats Jirstrand,

Frontiers in Physiology

2016

47

Translational pharmacokinetic–pharmacodynamic modeling of QTc effects in dog and human

Joanna Parkinson, Sandra A. G. Visser, Philip Jarvis,

Journal of Pharmacological and Toxicological Methods

2013

39

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study

Austin G. Stack, David Han, Ronald Goldwater,

The Journal of Clinical Endocrinology & Metabolism

2020

37

A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease

Viknesh Selvarajah, Darren Robertson, Lars Hansen,

Kidney International

2024

26

Application of Data Mining and Visualization Techniques for the Prediction of Drug-Induced Nausea in Man

Joanna Parkinson, Daniel Muthas, Matthew Clark,

Toxicological Sciences

2011

25

Model‐Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes

Heeseung Jo, Venkatesh Pilla Reddy, Joanna Parkinson,

CPT Pharmacometrics & Systems Pharmacology

2021

24

Comparison of the exposure–response relationship of dapagliflozin in adult and paediatric patients with type 2 diabetes mellitus

Joanna Parkinson, Weifeng Tang, C.‐J. JOHANSSON,

Diabetes Obesity and Metabolism

2016

19

Effects of isopropanol on collagen fibrils in new parchment

Lee Gonzalez, Jennifer Hiller, Nicholas J. Terrill,

Chemistry Central Journal

2012

15

Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

David Busse, Weifeng Tang, Markus F. Scheerer,

British Journal of Clinical Pharmacology

2019

14

Page 1